Biosimilar Hormones Global Market Report 2021: COVID-19 Growth And Change To 2030

Biosimilar Hormones Global Market Report 2021: COVID-19 Growth And Change To 2030

Biosimilar Hormones Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar hormones market.

This report focuses on biosimilar hormones market which is experiencing strong growth. The report gives a guide to the biosimilar hormones market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:

Where is the largest and fastest growing market for the biosimilar hormones? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Biosimilar hormones market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider biosimilar hormones market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The biosimilar hormones market section of the report gives context. It compares the biosimilar hormones market with other segments of the biosimilar hormones market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biosimilar hormones indicators comparison.
Scope

Markets Covered: 1) By Type: Teriparatide Biosimilars; Follitropin Alfa Biosimilars; Insulin Biosimilars; Somatropin Biosimilars; Others

2) By Application: Research & Biotechnology; Diagnostics; Biocatalysts; Therapeutics; Others

3) By Distribution Channel: Hospital And Retail Pharmacy; Online Pharmacy/epharmacy; Speciality Clinics

Companies Mentioned: Teva Pharmaceutical; Gedeon Richter; Intas Pharmaceuticals; Biocon; Mylan

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Biosimilar Hormones Market Characteristics
3. Biosimilar Hormones Market Trends And Strategies
4. Impact Of COVID-19 On Biosimilar Hormones
5. Biosimilar Hormones Market Size And Growth
5.1. Global Biosimilar Hormones Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Biosimilar Hormones Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Biosimilar Hormones Market Segmentation
6.1. Global Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Teriparatide Biosimilars
Follitropin Alfa Biosimilars
Insulin Biosimilars
Somatropin Biosimilars
Others
6.2. Global Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Research & biotechnology
Diagnostics
Biocatalysts
Therapeutics
Others
6.3. Global Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Hospital and Retail Pharmacy
Online Pharmacy/ePharmacy
Speciality Clinics
7. Biosimilar Hormones Market Regional And Country Analysis
7.1. Global Biosimilar Hormones Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Biosimilar Hormones Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Biosimilar Hormones Market
8.1. Asia-Pacific Biosimilar Hormones Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Biosimilar Hormones Market
9.1. China Biosimilar Hormones Market Overview
9.2. China Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Biosimilar Hormones Market
10.1. India Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Biosimilar Hormones Market
11.1. Japan Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Biosimilar Hormones Market
12.1. Australia Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Biosimilar Hormones Market
13.1. Indonesia Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Biosimilar Hormones Market
14.1. South Korea Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Biosimilar Hormones Market
15.1. Western Europe Biosimilar Hormones Market Overview
15.2. Western Europe Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Biosimilar Hormones Market
16.1. UK Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Biosimilar Hormones Market
17.1. Germany Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Biosimilar Hormones Market
18.3. France Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Biosimilar Hormones Market
19.1. Eastern Europe Biosimilar Hormones Market Overview
19.2. Eastern Europe Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Biosimilar Hormones Market
20.1. Russia Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Biosimilar Hormones Market
21.1. North America Biosimilar Hormones Market Overview
21.2. North America Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Biosimilar Hormones Market
22.1. USA Biosimilar Hormones Market Overview
22.2. USA Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Biosimilar Hormones Market
23.1. South America Biosimilar Hormones Market Overview
23.2. South America Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Biosimilar Hormones Market
24.1. Brazil Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Biosimilar Hormones Market
25.1. Middle East Biosimilar Hormones Market Overview
25.2. Middle East Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Biosimilar Hormones Market
26.1. Africa Biosimilar Hormones Market Overview
26.2. Africa Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Biosimilar Hormones Market Competitive Landscape And Company Profiles
27.1. Biosimilar Hormones Market Competitive Landscape
27.2. Biosimilar Hormones Market Company Profiles
27.2.1. Teva Pharmaceutical
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Gedeon Richter
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Intas Pharmaceuticals
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Biocon
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Mylan
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Biosimilar Hormones Pipeline Analysis
29. Key Mergers And Acquisitions In The Biosimilar Hormones Market
30. Biosimilar Hormones Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. The Business Research Company
31.5. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings